182 related articles for article (PubMed ID: 17899491)
1. Carisbamate, a new carbamate for the treatment of epilepsy.
Kulig K; Malawska B
IDrugs; 2007 Oct; 10(10):720-7. PubMed ID: 17899491
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study.
Trenité DG; French JA; Hirsch E; Macher JP; Meyer BU; Grosse PA; Abou-Khalil BW; Rosenfeld WE; van Gerven J; Novak GP; Parmeggiani L; Schmidt B; Gibson D; Guerrini R
Epilepsy Res; 2007 May; 74(2-3):193-200. PubMed ID: 17448639
[TBL] [Abstract][Full Text] [Related]
3. Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS.
François J; Boehrer A; Nehlig A
Epilepsia; 2008 Mar; 49(3):393-9. PubMed ID: 17822432
[TBL] [Abstract][Full Text] [Related]
4. Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons.
Liu Y; Yohrling GJ; Wang Y; Hutchinson TL; Brenneman DE; Flores CM; Zhao B
Epilepsy Res; 2009 Jan; 83(1):66-72. PubMed ID: 19013768
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
6. Carisbamate (RWJ-333369).
Novak GP; Kelley M; Zannikos P; Klein B
Neurotherapeutics; 2007 Jan; 4(1):106-9. PubMed ID: 17199023
[TBL] [Abstract][Full Text] [Related]
7. The novel antiepileptic drug carisbamate (RWJ 333369) is effective in inhibiting spontaneous recurrent seizure discharges and blocking sustained repetitive firing in cultured hippocampal neurons.
Deshpande LS; Nagarkatti N; Sombati S; DeLorenzo RJ
Epilepsy Res; 2008 May; 79(2-3):158-65. PubMed ID: 18353614
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, safety, and tolerability of the new antiepileptic carisbamate in the elderly.
Levy R; Ragueneau-Majlessi I; Solanki B; Zannikos P; Yao C; Novak G
Epilepsy Res; 2008 Mar; 79(1):22-30. PubMed ID: 18280116
[TBL] [Abstract][Full Text] [Related]
9. Carisbamate prevents the development and expression of spontaneous recurrent epileptiform discharges and is neuroprotective in cultured hippocampal neurons.
Deshpande LS; Nagarkatti N; Ziobro JM; Sombati S; DeLorenzo RJ
Epilepsia; 2008 Oct; 49(10):1795-802. PubMed ID: 18494784
[TBL] [Abstract][Full Text] [Related]
10. A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy.
Grabenstatter HL; Dudek FE
Epilepsia; 2008 Oct; 49(10):1787-94. PubMed ID: 18494790
[TBL] [Abstract][Full Text] [Related]
11. Measurement of anticonvulsant activity in the Papio papio model of epilepsy.
Killam EK
Fed Proc; 1976 Sep; 35(11):2264-9. PubMed ID: 821787
[TBL] [Abstract][Full Text] [Related]
12. Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
Borowicz KK; Malek R; Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
Epilepsy Behav; 2007 Aug; 11(1):6-12. PubMed ID: 17602881
[TBL] [Abstract][Full Text] [Related]
13. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use.
Large CH; Sokal DM; Nehlig A; Gunthorpe MJ; Sankar R; Crean CS; Vanlandingham KE; White HS
Epilepsia; 2012 Mar; 53(3):425-36. PubMed ID: 22221318
[TBL] [Abstract][Full Text] [Related]
15. [Experimental basis for the treatment of drug-resistant epilepsy].
Błaszczyk B; Trojnar M; Czuczwar SJ
Przegl Lek; 2006; 63(11):1221-3. PubMed ID: 17348421
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro.
Whalley BJ; Stephens GJ; Constanti A
Br J Pharmacol; 2009 Mar; 156(6):994-1008. PubMed ID: 19226287
[TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant and antiepileptogenic effects of azolylchromanones on lithium-pilocarpine induced seizures and pentylenetetrazole-kindling model of epilepsy.
Kebriaeezadeh A; Emami S; Ebrahimi M; Sharifzadeh M; Khorasani R; Shafiee A
Biomed Pharmacother; 2008; 62(4):208-11. PubMed ID: 18222059
[TBL] [Abstract][Full Text] [Related]
18. An interaction study between the new antiepileptic and CNS drug carisbamate (RWJ-333369) and lamotrigine and valproic acid.
Chien S; Yao C; Mertens A; Verhaeghe T; Solanki B; Doose DR; Novak G; Bialer M
Epilepsia; 2007 Jul; 48(7):1328-38. PubMed ID: 17381436
[TBL] [Abstract][Full Text] [Related]
19. The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans.
Mannens GS; Hendrickx J; Janssen CG; Chien S; Van Hoof B; Verhaeghe T; Kao M; Kelley MF; Goris I; Bockx M; Verreet B; Bialer M; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):554-65. PubMed ID: 16936066
[TBL] [Abstract][Full Text] [Related]
20. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
